← Leaderboards
Karen L Christman
University Of California Los Angeles
$19,606,702
Attributed
$33,699,781
Total exposure
18
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,699,781 · 18
By mechanism
R01$20,468,056 · 8
UC4$4,909,262 · 1
DP2$2,431,773 · 1
R44$2,059,825 · 1
R43$1,288,473 · 2
T32$1,274,752 · 1
Top collaborators
- Marianna Alperin13 shared
- Nathan Claude Gianneschi12 shared
- Michael E Davis4 shared
- Adam M Kinsey4 shared
- Andrew D. Mcculloch4 shared
- Geert W. Schmid-Schoenbein4 shared
- Steven Carl George3 shared
- Christopher C. W. Hughes3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Alexander M Cole$10,641,954
- Soban Umar$2,400,392
- Timothy McKinsey$12,803,870
Others in their field
Top investigators on “Biocompatible Materials”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$109,756,899
- Thomas T Perls · Beth Israel Deaconess Medical Center$38,971,164
- Jonathan S Lewin · Case Western Reserve University$37,486,163
- Sean McSweeney · Brookhaven Science Assoc-Brookhaven Lab$36,732,078
- Daniel H Geschwind · University Of California Los Angeles$35,924,551
- Ravi Thadhani · Brigham And Women'S Hospital$32,923,409
Research focus
Biocompatible MaterialsExtracellular MatrixCellsRattusMinimally InvasiveTissuesInjectableScaffoldTissue EngineeringHistologyHydrogelsCardiacMyocardial InfarctionRepairedBaseMyocardialFamily SuidaeAnimalsHeart FailureTranslationsCathetersCell TherapyInnovationHeart
Grant awards (63)
Infusible Extracellular Matrix for Treating Myocardial Infarction$736,843
R01 · FY2025 · HL · contact PI
MMP responsive polymeric materials for treating acute myocardial infarction$580,572
R01 · FY2025 · HL · contact PI
Regenerative biomaterial for combating genitourinary syndrome of menopause$467,837
R01 · FY2025 · AG
Training in Bioengineering Research and Technology Development in Cardiovascular in Cardiopulmonary Health and Disease$310,806
T32 · FY2025 · HL
Infusible Extracellular Matrix for Treating Myocardial Infarction$722,093
R01 · FY2024 · HL · contact PI
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel$622,760
R01 · FY2024 · HD
MMP responsive polymeric materials for treating acute myocardial infarction$569,855
R01 · FY2024 · HL · contact PI
Regenerative biomaterial for combating genitourinary syndrome of menopause$532,719
R01 · FY2024 · AG
Pathways underlying recovery of injured urethral sphincter and a novel regenerative biomaterial intervention$527,065
R01 · FY2024 · DK
Training in Bioengineering Research and Technology Development in Cardiovascular in Cardiopulmonary Health and Disease$319,152
T32 · FY2024 · HL
Infusible Extracellular Matrix for Treating Myocardial Infarction$735,664
R01 · FY2023 · HL · contact PI
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel$637,646
R01 · FY2023 · HD
MMP responsive polymeric materials for treating acute myocardial infarction$597,347
R01 · FY2023 · HL · contact PI
Pathways underlying recovery of injured urethral sphincter and a novel regenerative biomaterial intervention$557,778
R01 · FY2023 · DK
Training in Bioengineering Research and Technology Development in Cardiovascular in Cardiopulmonary Health and Disease$325,449
T32 · FY2023 · HL
Infusible Extracellular Matrix for Treating Myocardial Infarction$734,553
R01 · FY2022 · HL · contact PI
Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome$724,183
R01 · FY2022 · HL
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel$637,646
R01 · FY2022 · HD
Pathways underlying recovery of injured urethral sphincter and a novel regenerative biomaterial intervention$549,026
R01 · FY2022 · DK
Training in Bioengineering Research and Technology Development in Cardiovascular in Cardiopulmonary Health and Disease$319,345
T32 · FY2022 · HL
Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome$753,981
R01 · FY2021 · HL
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel$637,646
R01 · FY2021 · HD
Pathways underlying recovery of injured urethral sphincter and a novel regenerative biomaterial intervention$557,778
R01 · FY2021 · DK
New infusible ECM hydrogel for treating acute myocardial infarction$791,543
R43 · FY2020 · HL
Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome$677,417
R01 · FY2020 · HL
Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel$648,601
R01 · FY2020 · HD
Extracellular Matrix Hydrogels for Treating Cardiomyopathy$387,500
R01 · FY2020 · HL · contact PI
MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction$387,500
R01 · FY2020 · HL · contact PI
Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome$678,054
R01 · FY2019 · HL
Extracellular Matrix Hydrogels for Treating Cardiomyopathy$387,500
R01 · FY2019 · HL · contact PI
MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction$387,500
R01 · FY2019 · HL · contact PI
Injectable Tissue-Specific Extracellular Matrix Hydrogel for Pelvic Skeletal Muscle Regeneration Following Birth Injury$193,750
R21 · FY2019 · HD
Promotion of Skeletal Muscle Recovery Using an Extracellular Matrix Hydrogel in a Rabbit Model of Chronic Rotator Cuff Injury$158,938
R21 · FY2019 · AR
Extracellular Matrix Hydrogels for Treating Cardiomyopathy$387,500
R01 · FY2018 · HL · contact PI
MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction$387,500
R01 · FY2018 · HL · contact PI
Injectable Tissue-Specific Extracellular Matrix Hydrogel for Pelvic Skeletal Muscle Regeneration Following Birth Injury$232,500
R21 · FY2018 · HD
Promotion of Skeletal Muscle Recovery Using an Extracellular Matrix Hydrogel in a Rabbit Model of Chronic Rotator Cuff Injury$194,090
R21 · FY2018 · AR
Extracellular Matrix Hydrogels for Treating Cardiomyopathy$387,500
R01 · FY2017 · HL · contact PI
MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction$387,500
R01 · FY2017 · HL · contact PI
A 3-D biomimetic human islet to model beta cell function in health and disease$961,943
UC4 · FY2016 · DK
Autonomously Assembling Nanomaterial Scaffolds for Treating Myocardial Infarction$387,500
R01 · FY2016 · HL · contact PI
A 3-D biomimetic human islet to model beta cell function in health and disease$33,480
UC4 · FY2016 · DK
Extracellular matrix hydrogels for treating ischemia$23,165
R01 · FY2016 · HL · contact PI
Extracellular matrix hydrogels for treating ischemia$397,830
R01 · FY2015 · HL · contact PI
Autonomously Assembling Nanomaterial Scaffolds for Treating Myocardial Infarction$387,500
R01 · FY2015 · HL · contact PI
A 3-D biomimetic human islet to model beta cell function in health and disease$3,913,839
UC4 · FY2014 · DK
Phase II: Percutaneous deliverable biomaterial for treating myocardial infarction$720,276
R44 · FY2014 · HL
Autonomously Assembling Nanomaterial Scaffolds for Treating Myocardial Infarction$387,500
R01 · FY2014 · HL · contact PI
Extracellular matrix hydrogels for treating ischemia$367,778
R01 · FY2014 · HL · contact PI
Extracellular matrix hydrogels for treating ischemia$30,072
R01 · FY2014 · HL · contact PI
Phase II: Percutaneous deliverable biomaterial for treating myocardial infarction$1,339,549
R44 · FY2013 · HL
Autonomously Assembling Nanomaterial Scaffolds for Treating Myocardial Infarction$375,875
R01 · FY2013 · HL · contact PI
Extracellular matrix hydrogels for treating ischemia$358,514
R01 · FY2013 · HL · contact PI
Autonomously Assembling Nanomaterial Scaffolds for Treating Myocardial Infarction$387,500
R01 · FY2012 · HL · contact PI
Extracellular matrix hydrogels for treating ischemia$377,758
R01 · FY2012 · HL · contact PI
Percutaneous deliverable biomaterial for treating myocardial infarction$496,930
R43 · FY2011 · HL
Enhanced cardiomyocyte differentiation and maturation using myocardial matrix$210,295
R21 · FY2011 · HL · contact PI
Enhanced cardiomyocyte differentiation and maturation using myocardial matrix$185,295
R21 · FY2010 · HL · contact PI
Engineering a Dynamic Extracellular Matrix Microenvironment$72,300
DP2 · FY2009 · OD · contact PI
Engineering a Dynamic Extracellular Matrix Microenvironment$41,973
DP2 · FY2009 · OD · contact PI
Engineering a Dynamic Extracellular Matrix Microenvironment$2,317,500
DP2 · FY2008 · OD · contact PI
Selective patterning of biomolecules into protein arrays$48,796
F32 · FY2006 · HL · contact PI
Selective patterning of biomolecules into protein arrays$43,976
F32 · FY2005 · HL